Hermogenyx shares soar on new partnership with Prevail Partners
18th Sep 2023 13:00
(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.
Read moreHemogenyx signs another deal with unnamed global pharma company
23rd Oct 2019 10:43
(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.
Read moreHemogenyx enters collaboration agreement with Orgenesis
19th Oct 2018 08:26
(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement with cell therapy outfit Orgenesis to further commercialise its humanised-mouse drug model.
Read moreHemogenyx inks lupus collaboration with Johnson and Johnson
15th Oct 2018 08:32
(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement industry giant Johnson and Johnson to develop a model of systemic lupus erythematosus, the most common form of Lupus.
Read more